Minerva Neurosciences, Inc. (NERV) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-12 | 8-K | Officer / Director Changes | SEC |
| 2026-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-04 | 8-K | Item 3.03, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-27 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-06 | 8-K | Other Events | SEC |
| 2026-04-02 | 8-K | Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-03 | 8-K | Reg FD Disclosure, Other Events | SEC |
| 2025-12-22 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-11-19 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-22 | 8-K | Material Agreement, Unregistered Sales, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-19 | 8-K | Other Events | SEC |
| 2025-01-13 | 8-K | Other Events | SEC |
| 2024-12-05 | 8-K | Shareholder Vote Results | SEC |
| 2024-10-11 | 8-K | Listing Notice | SEC |
| 2024-09-16 | 8-K | Other Events | SEC |
| 2024-05-30 | 8-K | Officer / Director Changes | SEC |
| 2024-04-12 | 8-K | Listing Notice | SEC |
| 2024-02-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.